BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7162464)

  • 21. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J; Marquez VE; Momparler RL
    Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines.
    Fukuda T; Kamishima T; Kakihara T; Ohnishi Y; Suzuki T
    Leuk Res; 1996; 20(11-12):931-9. PubMed ID: 9009251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Deamination of Arabinosylcytosine (NSC-63878) by Rhodium(II) Acetate.
    Lee SH; Chao DL; Bear JL; Kimball AP
    Cancer Chemother Rep; 1975; 59(3):661-3. PubMed ID: 1203890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts.
    Ruiz van Haperen VW; Veerman G; Braakhuis BJ; Vermorken JB; Boven E; Leyva A; Peters GJ
    Eur J Cancer; 1993; 29A(15):2132-7. PubMed ID: 8297652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low cytidine deaminase levels in human hematopoietic cell lines.
    Nygaard P; Sundström C
    Leuk Res; 1987; 11(8):681-5. PubMed ID: 3626611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytosine and cytidine deaminase from yeast.
    Ipata PL; Cercignani G
    Methods Enzymol; 1978; 51():394-400. PubMed ID: 357899
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C; Barra Y; Carcassonne Y; Cano JP; Rustum Y
    Chemotherapy; 1992; 38(5):358-66. PubMed ID: 1286578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the role of cytidine deaminase in cellular metabolism.
    Nygaard P
    Adv Exp Med Biol; 1986; 195 Pt B():415-20. PubMed ID: 3532704
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxicity of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine and its relationship to deoxycytidine deaminase.
    Cheng YC; Tan RS; Ruth JL; Dutschman G
    Biochem Pharmacol; 1983 Feb; 32(4):726-9. PubMed ID: 6830635
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A; Verhoef V
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract]   [Full Text] [Related]  

  • 31. SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.
    Mahlknecht U; Dransfeld CL; Bulut N; Kramer M; Thiede C; Ehninger G; Schaich M
    Leukemia; 2009 Oct; 23(10):1929-32. PubMed ID: 19458626
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytidine deaminase: a new genetic polymorphism demonstrated in human granulocytes.
    Teng YS; Anderson JE; Giblett ER
    Am J Hum Genet; 1975 Jul; 27(4):492-7. PubMed ID: 50738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cell growth and cell differentiation on 1-beta-D-arabinofuranosylcytosine metabolism in myeloid cells.
    Chiba P; Tihan T; Eher R; Köller U; Wallner C; Göbl R; Linkesch W
    Br J Haematol; 1989 Apr; 71(4):451-5. PubMed ID: 2713269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dancin' deaminase.
    Harris RS; Matsuo H
    Nat Struct Mol Biol; 2006 May; 13(5):380-1. PubMed ID: 16738602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saturation of intracellular cytosine arabinoside triphosphate accumulation in human leukemic blast cells.
    Jamieson GP; Snook MB; Wiley JS
    Leuk Res; 1990; 14(5):475-9. PubMed ID: 2345470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of alternative synthetic and catabolic purine pathways in T lymphocyte differentiation.
    Cohen A; Barankiewicz J; Gelfand EW
    Ann N Y Acad Sci; 1985; 451():26-33. PubMed ID: 3000256
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells.
    Pemble LB; Lihou MG; Blakley RL; Jamieson GP; Smith PJ
    Cancer Chemother Pharmacol; 1987; 20(2):155-61. PubMed ID: 3499252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
    Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytidine and deoxycytidine aminohydrolase activities from Zea mays L. aerial parts: probable existence of two isozymes both of which possess the two activities].
    Guillot A; Brillard M
    Biochimie; 1979; 61(3):379-84. PubMed ID: 454689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M; Yoshida S
    Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.